The latest closing stock price for Cadrenal Therapeutics as of June 27, 2025 is 10.44.
An investor who bought $1,000 worth of Cadrenal Therapeutics stock at the IPO in 2023 would have $-831 today, roughly -1 times their original investment - a -58.90% compound annual growth rate over 2 years.
The all-time high Cadrenal Therapeutics stock closing price was 61.80 on January 20, 2023.
The Cadrenal Therapeutics 52-week high stock price is 22.90, which is 119.3% above the current share price.
The Cadrenal Therapeutics 52-week low stock price is 5.70, which is 45.4% below the current share price.
The average Cadrenal Therapeutics stock price for the last 52 weeks is 13.86.
An investor who bought $1,000 worth of Cadrenal Therapeutics stock at the IPO in 2023 would have $-831 today, roughly -1 times their original investment - a -58.90% compound annual growth rate over 2 years.
The all-time high Cadrenal Therapeutics stock closing price was 61.80 on January 20, 2023.
The Cadrenal Therapeutics 52-week high stock price is 22.90, which is 119.3% above the current share price.
The Cadrenal Therapeutics 52-week low stock price is 5.70, which is 45.4% below the current share price.
The average Cadrenal Therapeutics stock price for the last 52 weeks is 13.86.